{"data":{"id":"us-nh/rsa-146-b-1","jurisdiction":"us-nh","citation":"RSA 146-B:1","heading":"Definitions.","body":"In this chapter:\nI. \"Department\" means the department of health and human services.\nII. \"Established name\" has the meaning given in section 502(e)(3) of the Federal Food, Drug and Cosmetic Act (21 U.S.C. 352(e)(3)).\nIII. \"Equivalent drug product\" means a therapeutically equivalent drug product with the same established name, active ingredient strength, quantity and dosage form as the drug product identified in the prescription.\nIV. \"Prescriber\" means a person licensed by the state to prescribe drug products.","path":["Title X: PUBLIC HEALTH","Chapter 146-B: DRUG PRODUCT SELECTION"],"source_url":"https://gc.nh.gov/rsa/html/X/146-B/146-B-1.htm","current_through":"2025 regular legislative session, or December 2025","vintage":"","retrieved_at":"2026-09-05T13:26:07Z","sha256":"c66f70916fcaf63e57e90326c48ca2fbab53f73b8d82d9161010fabdb2b7c020","source_id":"us-nh","stale":false,"prev":"us-nh/rsa-146-a-19","next":"us-nh/rsa-146-b-2"},"notice":"GroundRules: Original legal text. Not legal advice."}